George Perry to United States
This is a "connection" page, showing publications George Perry has written about United States.
Connection Strength
0.256
-
Analysis of Alzheimer's Disease-Related Mortality Rates Among the Elderly Populations Across the United States: An Analysis of Demographic and Regional Disparities from 1999 to 2020. Curr Alzheimer Res. 2024; 21(6):384-394.
Score: 0.083
-
Mark A. Smith: the scientist, the man. Int J Exp Pathol. 2011 Oct; 92(5):297-8.
Score: 0.036
-
Is US residence a risk factor for Alzheimer's disease? J Alzheimers Dis. 2025 Sep; 107(2):496-498.
Score: 0.023
-
Associations of semaglutide with first-time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real-world data in the US. Alzheimers Dement. 2024 Dec; 20(12):8661-8672.
Score: 0.022
-
The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes. J Alzheimers Dis. 2023; 94(2):497-507.
Score: 0.019
-
Making the Case for Accelerated Withdrawal of Aducanumab. J Alzheimers Dis. 2022; 87(3):1003-1007.
Score: 0.018
-
No Evidence of Increased Chronic Traumatic Encephalopathy Pathology or Neurodegenerative Proteinopathy in Former Military Service Members: A Preliminary Study. J Alzheimers Dis. 2019; 67(4):1277-1289.
Score: 0.015
-
Putative Gonadotropin-Releasing Hormone Agonist Therapy and Dementia: An Application of Medicare Hospitalization Claims Data. J Alzheimers Dis. 2018; 63(4):1269-1277.
Score: 0.014
-
Social justice and disadvantaged groups. Hastings Cent Rep. 2007 Jul-Aug; 37(4):32-9.
Score: 0.013
-
Alzheimer disease research in the 21st century: past and current failures, new perspectives and funding priorities. Oncotarget. 2016 Jun 28; 7(26):38999-39016.
Score: 0.012